New Drugs, Insomnia, Depression/ Anxiety, and Herpes Zoster/ Postherpetic Neuralgia

Recorded November 15, 2023. This course is course is valid until November 15, 2026 and may be taken for credit up to that time.

• TOPIC 1: New Drug Update 2023: What’s Hot and What’s Not: Part 2

  • Identify new primary care medications approved in 2022-23.

  • Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.

  • Discuss updates related to labeling, indications, risks associated with various medications.

• TOPIC 2: Managing Insomnia Across the Lifespan: Latest Treatment Options:

  • Discuss the incidence and prevalence of insomnia across the lifespan.

  • Identify the appropriate work-up of the individual with insomnia.

  • Discuss pharmacologic treatment options for the patient with insomnia.

• TOPIC 3: Treating Depression and Anxiety in Primary Care in 2023:

  • Latest in Pharmacologic Treatment Options:

  • Discuss signs and symptoms of the patient with depression and anxiety (sadness, changes in sleep, appetite and mood.)

  • Discuss various pharmacologic treatments for the patient with depression and anxiety.

  • Compare and contrast various pharmacologic agents currently available.

• TOPIC 4: Postherpetic Neuralgia: Getting to the Root of this Painful Legacy

  • Describe the etiology and pathophysiology of herpes zoster and postherpetic neuralgia.

  • Identify signs and symptoms of herpes zoster and postherpetic neuralgia

  • Discuss acute treatment options for the individual with herpes zoster and postherpetic neuralgia.

ACCREDITATION

• University Learning Systems is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.

• California Board of Registered Nursing Provider No. CEP 11409, for 5 contact hours (0.5 CEU).

• CE Broker Tracking #: 50-11357

PRINCIPAL AUDIENCE

PHARMACISTS: University Learning Systems reports credit to CPE Monitor. This course provides 5 contact hours (0.5 CEU). Part 1: 0741-0000-23-025-H01-P

ACTIVITY: APPLICATION. No Partial credit is awarded. This course is course is valid until December 7, 2026 and may be taken for credit up to that time.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).

NURSE PRACTITIONERS/NURSES: This course provides 5 contact hours (0.5 CEU) of pharmacotherapeutics / pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

OTHER HEALTH PROFESSIONALS: Please contact your respective board.

PHYSICIANS: This course may be considered for AMA Category 2 credit only.

CANADIAN PHYSICIANS: This course may be considered for AMA Category 2 credit only which may be equivalent to MAINPRO-M2 credits. Please contact your respective board.

PHYSICIAN ASSISTANTS: This course may be considered for AMA Category 2 credit only.